Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852722 · ClinicalTrials.gov registry record · Phase 1
Low Fat Diet and Multiple Sclerosis
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 61
- Enrollment target
NCT00852722 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 61 participants.
The verdict
NCT00852722, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if following a specific low fat diet will improve the brain damage as seen by Magnetic Resonance Imaging (MRI) and to decrease the progression of multiple sclerosis (MS) as evidenced by clinical evaluation and symptoms.
Interventions
- OTHER Low fat study diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2009-02 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852722
The ClinicalTrials.gov registry entry for NCT00852722 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low fat study diet is the first listed.
NCT00852722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852722 about?
NCT00852722 is a clinical study titled "Low Fat Diet and Multiple Sclerosis". The purpose of this study is to evaluate if following a specific low fat diet will improve the brain damage as seen by Magnetic Resonance Imaging (MRI) and to decrease the progression of multiple sclerosis (MS) as evidenced by clinical evaluation and symptoms.
What is the current status of trial NCT00852722?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2009-02. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00852722?
The interventions under investigation include: Low fat study diet (OTHER).
Who is sponsoring clinical trial NCT00852722?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.